Company:  ASTEX PHARMACEUTICALS, IN ...
Form Type:  10-Q
Filing Date:  11/9/2011 
CIK:  0000919722 
Address:  4140 DUBLIN BLVD
SUITE 200
 
City, State, Zip:  DUBLIN, California 94568 
Telephone:  (925) 560-0100 
Fiscal Year:  12/31 
Description of Business
We incorporated in March 1991 as a California corporation and changed our state of incorporation to Delaware in May 1997. We changed our name from SuperGen, Inc. to Astex Pharmaceuticals, Inc. in September 2011. Our executive offices are located at 4140 Dublin Blvd., Suite 200, Dublin, CA, 94568 and our telephone number at that address is (925) 560-0100. We maintain a website on the internet at www.astx.com. This is a textual reference only. We do not incorporate the information on our website into this annual report on Form 10-K, and you should not consider any information on, or that can be accessed through, our website as part of this annual report on Form 10-K. Overview We are dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology and hematology. We are developing a pipeline of novel medicines for partnership with leading pharmaceutical companies.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I
      FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
      Item 2. Management's Discussion and Analysis of Financial ...
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures
    PART II-OTHER INFORMATION
      Item 1A. Risk Factors
      Item 6. Exhibits
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL ...
BROKERAGE PARTNERS